This makes Ptch1 a particularly attractive therapeutic target to enhance the effectiveness of classical chemotherapeutic treatments, and to decrease the risk of recurrence and metastasis in cancers expressing Ptch1. This evidence concerns the gene PTCH1 and cancer.